In patients with previously treated metastatic pancreatic adenocarcinoma, does daraxonrasib improve overall survival and progression-free survival compared with standard chemotherapy, while being safe?

Rasonque (daraxonrasib) - Revolution Medicines

http://www.ncbi.nlm.nih.gov/pubmed/42731942

Alexandre Mutchmore; Giulia Pool; Luc Lanthier; Marc-Émile Plourde; Michel Cauchon

Sep 13, 2026